On November 18, 2021 GT Medical Technologies, Inc. a company dedicated to improving the lives of patients with brain tumors, reported upcoming presentations related to its breakthrough GammaTile Therapy at the 26th Annual Meeting of the Society for Neuro-Oncology (SNO) being held in Boston November 18-21, 2021 (Press release, GT Biopharma, NOV 18, 2021, View Source [SID1234595825]). In total, GammaTile will be showcased in seven clinical presentations as well as an Industry-Sponsored Symposium.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
"We look forward to sharing updated data, clinical experiences of GammaTile users, and ongoing trials evaluating GammaTile Therapy with our neuro-oncology colleagues at the SNO conference this week," said Matthew E. Likens, president and CEO of GT Medical Technologies, Inc. "These presentations add to the mounting clinical evidence supporting the use of GammaTile Therapy in patients with brain tumors."
A list of educational presentations and their respective authors are below. The full text of these presentations is available in the November supplement of Neuro-Oncology, the official journal of the Society for Neuro-Oncology.
Poster Session: Friday, November 19th, 7:30 PM – 9:30 PM, Exhibit Hall D
A Multicenter Observational Study Of Cs-131 Seeds Embedded In A Collagen Carrier Tile For Newly Diagnosed And Recurrent Operable Intracranial Neoplasms –Trial In Progress, Erin Dunbar, MD
Successful Safety And Efficacy Of GammaTile Intracranial Brachytherapy Implanted During Awake Craniotomy, Ulysses G. Gardner, Jr., MD, MBA
Phase III Multicenter RCT Of Post-Surgical Stereotactic Radiotherapy Versus Surgically Targeted Radiation Therapy For The Treatment Of Large Newly Diagnosed Brain Metastases – Trial In Progress, Jeffrey S. Weinberg, MD
Access To Specialty Radiation Care For Patients With Resectable Brain Tumors, Mehee Choi, MD
Lunch Independent Symposium Session: Saturday, November 20th, 12:45 PM – 1:45 PM
GammaTile Therapy: Surgically Targeted Radiation Therapy For Brain Tumors, David Brachman, MD, Clark C. Chen, MD, PhD, Erin Dunbar, MD, Brandon Imber, MD
Abstract Session: Sunday, November 21st, 10:10 AM – 10:15 AM, Room 208
First Experience With Maximal Safe Resection And GammaTile Brachytherapy As Treatment For Recurrent Glioblastoma, Clark C. Chen, MD, PhD
Concurrent Session: Sunday, November 21st, 11:50 AM – 12:10 PM, Ballroom C
Revisiting Brachytherapy In The Treatment Of Recurrent Glioblastoma, Peter Nakaji, MD
Published Abstract Available Online
Resection And Surgically Targeted Radiation Therapy For Treatment Of Locally Recurrent GBM In 28 Prospectively Treated Patients, Kris Smith, MD